IP Explained: Four things to know about the Bayh-Dole Act

Thanks in large part to strong intellectual property protections – including policies that incentivize public and private investments in research and development (R&D) – the United States is theglobal leader in biopharmaceutical innovation. We ’vepreviously examined how the public and private sectors play complimentary roles with the biopharmaceutical industry doing the majority of R&D that translates basic science into new medicines. In today ’s IP Explained, we are going to take a closer look atthe Bayh-Dole Act and how it laid the foundation for effective technology transfer that modernized the U.S. economy, set a global precedent and is helping patients today.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Research and Development Intellectual Property IP Explained Source Type: news